Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Revenue (2016)

Historic Revenue for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Q4 2016 value amounting to $525000.0.

  • Rocket Pharmaceuticals' Revenue changed N/A to $525000.0 in Q4 2016 from the same period last year, while for Sep 2017 it was $525000.0, marking a year-over-year change of. This contributed to the annual value of -$1.2 million for FY2015, which is 2551.02% down from last year.
  • Per Rocket Pharmaceuticals' latest filing, its Revenue stood at $525000.0 for Q4 2016.
  • In the past 5 years, Rocket Pharmaceuticals' Revenue ranged from a high of $525000.0 in Q4 2016 and a low of -$525000.0 during Q3 2016